TAYLOR GARCIA: Open Payments
NPI 1760056592 · FAIRFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,653 in 103 payments from 14 companies in 2025. Trend: 2023 $1,798 · 2024 $3,309 · 2025 $2,653
Food & beverage: $2,653
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 26 | $447 |
| Alkermes, Inc. | 11 | $389 |
| Otsuka America Pharmaceutical, Inc. | 14 | $290 |
| Teva Pharmaceuticals USA, Inc. | 6 | $263 |
| ABBVIE INC. | 14 | $209 |
| Janssen Pharmaceuticals, Inc | 4 | $205 |
| Vanda Pharmaceuticals Inc. | 3 | $196 |
| Lundbeck LLC | 8 | $174 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 5 | $117 |
Products named: CAPLYTA, REXULTI, ARISTADA, VRAYLAR, INVEGA SUSTENNA, AUSTEDO XR, FANAPT, LYBALVI.
Industry payments across CA — which companies pay providers there.
